Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Azenta Inc (AZTA)

Azenta Inc (AZTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,743,941
  • Shares Outstanding, K 45,990
  • Annual Sales, $ 593,820 K
  • Annual Income, $ -55,760 K
  • EBIT $ -27 M
  • EBITDA $ 33 M
  • 60-Month Beta 1.32
  • Price/Sales 2.94
  • Price/Cash Flow 20.92
  • Price/Book 1.01

Options Overview Details

View History
  • Implied Volatility 62.45% (+7.84%)
  • Historical Volatility 34.65%
  • IV Percentile 56%
  • IV Rank 40.81%
  • IV High 97.37% on 10/20/25
  • IV Low 38.38% on 02/05/25
  • Expected Move (DTE 3) 9.23 (24.59%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 774
  • Open Int (30-Day) 817
  • Expected Range 28.31 to 46.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.11
  • Number of Estimates 1
  • High Estimate 0.11
  • Low Estimate 0.11
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.94 +13.96%
on 01/02/26
38.55 -2.62%
on 01/09/26
+2.24 (+6.35%)
since 12/12/25
3-Month
28.83 +30.21%
on 11/18/25
38.55 -2.62%
on 01/09/26
+7.73 (+25.93%)
since 10/10/25
52-Week
23.91 +57.01%
on 05/07/25
55.63 -32.52%
on 02/06/25
-14.16 (-27.39%)
since 01/10/25

Most Recent Stories

More News
Why Are Azenta (AZTA) Shares Soaring Today

Why Are Azenta (AZTA) Shares Soaring Today

AZTA : 37.54 (-1.00%)
1 High-Flying Stock with Impressive Fundamentals and 2 We Find Risky

1 High-Flying Stock with Impressive Fundamentals and 2 We Find Risky

AMSC : 30.47 (-0.65%)
AZTA : 37.54 (-1.00%)
ZG : 67.14 (-0.03%)
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

BURLINGTON, Mass. , Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical...

AZTA : 37.54 (-1.00%)
Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings?

Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings?

AZTA : 37.54 (-1.00%)
3 Overrated Stocks We Steer Clear Of

3 Overrated Stocks We Steer Clear Of

HNST : 2.58 (unch)
CROX : 87.09 (+1.19%)
AZTA : 37.54 (-1.00%)
Azenta Authorizes $250 Million Share Repurchase Program

BURLINGTON, Mass. , Dec. 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase...

AZTA : 37.54 (-1.00%)
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

JAZZ : 163.68 (+1.58%)
AZTA : 37.54 (-1.00%)
AMRX : 12.98 (+0.15%)
Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks

Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks

AZTA : 37.54 (-1.00%)
Why Azenta (AZTA) Stock Is Trading Up Today

Why Azenta (AZTA) Stock Is Trading Up Today

AZTA : 37.54 (-1.00%)
AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion

AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion

AZTA : 37.54 (-1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta...

See More

Key Turning Points

3rd Resistance Point 39.10
2nd Resistance Point 38.59
1st Resistance Point 38.07
Last Price 37.54
1st Support Level 37.03
2nd Support Level 36.52
3rd Support Level 36.00

See More

52-Week High 55.63
Fibonacci 61.8% 43.52
Fibonacci 50% 39.77
Last Price 37.54
Fibonacci 38.2% 36.03
52-Week Low 23.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar